RECURRENCE RATE OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH HCC AND VIRUS C COMPENSATED CIRRHOSIS TREATED WITH OMBITASVIR, PARITAPREVIR/R+DASABUVIR+RIBAVIRIN

Irina Sandra    

Conference
UEG Week 2018


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing